Literature DB >> 27129760

Hospital, Patient, and Clinical Factors Influence 30- and 90-Day Readmission After Primary Total Hip Arthroplasty.

Steven M Kurtz1, Edmund C Lau2, Kevin L Ong3, Edward M Adler4, Frank R Kolisek5, Michael T Manley6.   

Abstract

BACKGROUND: The purpose of this study was to analyze the hospital, clinical, and patient factors associated with inpatient readmission after total hip arthroplasty (THA) in the Medicare population and to understand the primary reasons for readmission.
METHODS: The Medicare 100% national hospital claims database was used to identify 442,333 older patients (65+) with a primary THA in 3730 hospitals between 2010 and 2013. A multilevel logistic regression analysis with a clustered data structure was used to investigate the risk of all-cause 30- and 90-day readmission, incorporating hospital, clinical, and patient factors.
RESULTS: At 30 days, 5.8% (median) of the patients were readmitted, whereas at 90 days, 10.5% (median) were readmitted. Geographic census region, hospital procedure volume, and nonprofit ownership were the only significant hospital factors among those we studied. Overall, clinical factors explained more of the variation in readmission rates than general hospital factors. Use of a perioperative transfusion was associated with 14% greater risk, patients discharged to home had 28% lower risk, and surgeon volume and length of stay were also significant risk factors. The top 5 most frequently reported primary reasons for 30-day readmission in THA were procedure related: dislocation (5.9%), deep infection (5.1%), wound infection (4.8%), periprosthetic fracture (4.4%), or hematoma (3.4%).
CONCLUSION: These findings support further optimization of the delivery of care-both intraoperative and postoperative-to reduce the broad variation in hospital readmissions.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  30 days; 90 days; Medicare; complications; readmission; total hip arthroplasty

Mesh:

Year:  2016        PMID: 27129760     DOI: 10.1016/j.arth.2016.03.041

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  27 in total

1.  Association of Pain on Hospital Discharge with the Risk of 30-Day Readmission in Patients with Total Hip and Knee Replacement.

Authors:  Ickpyo Hong; Jordan R Westra; James S Goodwin; Amol Karmarkar; Yong-Fang Kuo; Kenneth J Ottenbacher
Journal:  J Arthroplasty       Date:  2020-07-03       Impact factor: 4.757

2.  Perioperative complications and causes of 30- and 90-day readmission after direct anterior approach primary total hip arthroplasty.

Authors:  Eric Sali; Jean-Luc Marmorat; Fabrice Gaudot; Christophe Nich
Journal:  J Orthop       Date:  2019-08-10

3.  Re-admissions treble the risk of late mortality after primary total hip arthroplasty.

Authors:  Pablo A Slullitel; Martín Estefan; Wilber M Ramírez-Serrudo; Fernando M Comba; Gerardo Zanotti; Francisco Piccaluga; Martín A Buttaro
Journal:  Int Orthop       Date:  2018-03-10       Impact factor: 3.075

4.  Outcomes Over 90-Day Episodes of Care in Medicare Fee-for-Service Beneficiaries Receiving Joint Arthroplasty.

Authors:  Addie Middleton; Yu-Li Lin; James E Graham; Kenneth J Ottenbacher
Journal:  J Arthroplasty       Date:  2017-03-30       Impact factor: 4.757

5.  Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?

Authors:  Steven M Kurtz; Edmund C Lau; Kevin L Ong; Edward M Adler; Frank R Kolisek; Michael T Manley
Journal:  Clin Orthop Relat Res       Date:  2017-12       Impact factor: 4.176

6.  Changes in Discharge to Rehabilitation: Potential Unintended Consequences of Medicare Total Hip Arthroplasty/Total Knee Arthroplasty Bundled Payments, Should They Be Implemented on a Nationwide Scale?

Authors:  Cheryl K Zogg; Jason R Falvey; Justin B Dimick; Adil H Haider; Kimberly A Davis; Johnathan N Grauer
Journal:  J Arthroplasty       Date:  2019-02-18       Impact factor: 4.757

7.  Evaluation of Intraoperative, Local Site Injections of Liposomal Bupivacaine as an Alternative to Standard Local Anesthetics in Patients Undergoing Total Hip Arthroplasty.

Authors:  Edward C Rainville; Carl Asche; Jinma Ren; MinChul Kim; Lucas Walker; B Ted Maurer; Daniel R Knolhoff; Kyle M Shick
Journal:  Hosp Pharm       Date:  2019-04-25

8.  Readmission Patterns Over 90-Day Episodes of Care Among Medicare Fee-for-Service Beneficiaries Discharged to Post-acute Care.

Authors:  Addie Middleton; Yong-Fang Kuo; James E Graham; Amol Karmarkar; Yu-Li Lin; James S Goodwin; Allen Haas; Kenneth J Ottenbacher
Journal:  J Am Med Dir Assoc       Date:  2018-10       Impact factor: 4.669

9.  Economic Impact of Outpatient Medicare Total Knee Arthroplasty at a Tertiary Care Academic Medical Center.

Authors:  Charles M Davis; Eric R Swenson; Travis M Lehman; Derek A Haas
Journal:  J Arthroplasty       Date:  2020-01-15       Impact factor: 4.757

10.  Spillover Effects of the Hospital Readmissions Reduction Program on Radical Cystectomy Readmissions.

Authors:  Matthew S Lee; Brent K Hollenbeck; Mary K Oerline; Ted A Skolarus; Bruce L Jacobs; Rita Jen; Amy N Luckenbaugh; Vahakn Shahinian; Tudor Borza
Journal:  Urol Pract       Date:  2018-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.